AS

Abdul Saleem Thasleem Begam

Active Director Director DIN 09367860
DIN 09367860 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdul Saleem Thasleem Begam

Data last updated:

Abdul Saleem Thasleem Begam is a Director at Al Siraat Labs Private Limited (since 2021). The company operates in Chemicals.

DIN 09367860
Primary Designation Director
Industry Chemicals
First Appointment 21 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Al Siraat Labs Private Limited U24290TN2021PTC147224
Director21 Oct 20212021Active

Board colleagues of Abdul Saleem Thasleem Begam

NameDINCompanyDesignation
Davood Basha Mubarakali09367859Al Siraat Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Al Siraat Labs Private Limited
Premium access

Shareholding and investment profile for Abdul Saleem Thasleem Begam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Saleem Thasleem Begam

Abdul Saleem Thasleem Begam currently holds 1 directorship: Al Siraat Labs Private Limited (Director, since 21 Oct 2021).

Abdul Saleem Thasleem Begam was first appointed on 21 Oct 2021 as Director at Al Siraat Labs Private Limited.

The current boards of Abdul Saleem Thasleem Begam's companies include Davood Basha Mubarakali (Al Siraat Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available